The Influence of Nutrition on Adiponectin—A Narrative Review
Abstract
:1. Introduction
2. Diet-Related Factors with a Positive Influence on Adiponectin Concentrations
2.1. Dietary Structure
2.1.1. The Mediterranean Diet
2.1.2. The DASH Diet
2.1.3. Plant-Based Diet
2.1.4. Low-Energy Diet
2.2. Nutrients and Products Included in the Diet
2.2.1. Monounsaturated Fatty Acids and Polyunsaturated Omega-3 Fatty Acids
2.2.2. Dietary Fiber
2.2.3. Polyphenols
2.2.4. Dairy Products
2.2.5. Alcohol
3. Diet-Related Factors with a Negative Influence on Adiponectin Concentrations
3.1. Dietary Structure
3.1.1. High-Carbohydrate and Low-Fat Diet
3.1.2. High Glycemic Index of the Diet
3.2. Nutrients and Products Included in the Diet
3.2.1. Saturated Fatty Acids and Trans Fatty Acids
3.2.2. Monosaccharides and Disaccharides
3.2.3. Red Meat
4. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Izadi, V.; Azadbakht, L. Specific dietary patterns and concentrations of adiponectin. J. Res. Med. Sci. 2015, 20, 178–184. [Google Scholar] [PubMed]
- Silva, F.M.; de Almeida, J.C.; Feoli, A.M. Effect of diet on adiponectin levels in blood. Nutr. Rev. 2011, 69, 599–612. [Google Scholar] [CrossRef] [PubMed]
- Sasso, F.C.; Pafundi, P.C.; Marfella, R.; Calabro, P.; Piscione, F.; Furbatto, F.; Esposito, G.; Galiero, R.; Gragano, F.; Rinaldi, L.; et al. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: The prospective AIRE Study. Cardiovasc. Diabetol. 2019, 18, 24–38. [Google Scholar] [CrossRef]
- Achari, A.E.; Jain, S.K. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int. J. Mol. Sci. 2017, 18, 1321–1338. [Google Scholar] [CrossRef] [Green Version]
- Fragopoulou, E.; Panagiotakos, D.B.; Pitsavos, C.; Tampourlou, M.; Chrysohoou, C.; Nomikos, T.; Antonopoulou, S.; Stefanadis, C. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: The ATTICA study. J. Nutr. Biochem. 2010, 21, 285–289. [Google Scholar] [CrossRef]
- Fang, H.; Judd, R.L. Adiponectin Regulation and Function. Compr. Physiol. 2018, 8, 1031–1063. [Google Scholar] [PubMed]
- Hermann, P.; Aulchenko, Y.S.; Frants, R.R.; Zorkoltseva, I.V.; Zillikens, M.C.; Frolich, M.; Oostra, B.A.; van Dijk, K.W.; van Duijn, C.M. Genetic architecture of plasma adiponectin overlaps with the genecits od metabolic syndrome-related traits. Diabetes. Care 2010, 33, 908–913. [Google Scholar]
- Cruz-Mejía, S.; López, H.H.D.; Meza, M.N.; Rosa, I.X.; Peña, S.; Helguera, O.E.A. Body mass index is associated with interleukin-1, adiponectin, oxidative stress and ioduria levels in healthy adults. Nutr. Hosp. 2018, 35, 841–846. [Google Scholar] [CrossRef]
- Ma, W.; Huang, T.; Wang, M.; Zheng, Y.; Wang, T.; Heianza, Y.; Sun, D.; Smith, S.R.; Bray, G.A.; Sacks, F.M.; et al. Two-year changes in circulating adiponectin, ectopic fat distribution and body composition in response to weight-loss diets: The POUNDS Lost Trial. Int. J. Obes. 2016, 40, 1723–1729. [Google Scholar] [CrossRef]
- Gariballa, S.; Alkaabi, J.; Yasin, J.; Al Essa, A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr. Disord. 2019, 19, 55–62. [Google Scholar] [CrossRef]
- Meshkini, M.; Alaei-Shahmiri, F.; Mamotte, C.; Dantas, J. Ethnic Variations in Adiponectin Levels and Its Association with Age, Gender, Body Composition and Diet: Differences Between Iranians, Indians and Europeans Living in Australia. J. Immigr. Minor. Health 2018, 20, 1362–1372. [Google Scholar] [CrossRef]
- Pischon, T.; Girman, C.J.; Rifai, N.; Hotamisligi, G.S.; Rimm, E.B. Association between dietary factors and plasma adiponectin concentrations in men. Am. J. Clin. Nutr. 2005, 81, 780–786. [Google Scholar] [CrossRef]
- Fargnoli, J.L.; Fung, T.T.; Olenczuk, D.M.; Chamberland, J.P.; Hu, F.B.; Mantzoros, C.S. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses’ Health Study. Am. J. Clin. Nutr. 2008, 88, 1213–1224. [Google Scholar]
- Volp, A.C.P.; Barbosa, K.B.F.; Bressan, J. Nutrients can modulate the adiponectin concentrations in apparently healthy young adults. Nutr. Hosp. 2016, 33, 580–587. [Google Scholar]
- Maiorino, M.I.; Bellastella, G.; Petrizzo, M.; Scappaticcio, L.; Giugliano, D.; Esposito, K. Mediterranean diet cools down the inflammatory milieu in type 2 diabetes: The MEDITA randomized controlled trial. Endocrine 2016, 54, 634–641. [Google Scholar] [CrossRef]
- Sureda, A.; Bibiloni, M.M.; Julibert, A.; Bouzas, C.; Argelich, E.; Llompart, I.; Pons, A.; Tur, J.A. Adherence to the Mediterranean Diet and Inflammatory Markers. Nutrients 2018, 10, 62–75. [Google Scholar] [CrossRef] [Green Version]
- Mantzoros, C.S.; Williams, C.J.; Manson, J.E.; Meigs, J.B.; Hu, F.B. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr. 2006, 84, 328–335. [Google Scholar] [CrossRef]
- Kouvari, M.; Boutari, C.; Chrysohoou, C.; Fragkopoulou, E.; Antonopoulou, S.; Tousoulis, D.; Pitsavos, C.; Panagiotakos, D.B.; Mantzoros, C.S. Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study. Clin. Nutr. 2020, 7, 1–11. [Google Scholar] [CrossRef]
- Luisi, M.L.E.; Lucarini, L.; Biffi, B.; Rafanelli, E.; Pietramellara, G.; Durante, M.; Vidali, S.; Provensi, G.; Madiai, S.; Gheri, C.F.; et al. Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects. Front. Endocrinol. 2019, 10, 1366–1379. [Google Scholar] [CrossRef] [Green Version]
- Spadafranca, A.; Piuri, G.; Bulfoni, C.; Liguori, I.; Battezzati, A.; Bertoli, S.; Speciani, A.F.; Ferrazzi, E. Adherence to the Mediterranean Diet and Serum Adiponectin Levels in Pregnancy: Results from a Cohort Study in Normal Weight Caucasian Women. Nutrients 2018, 10, 928–936. [Google Scholar] [CrossRef] [Green Version]
- Schwingshackl, L.; Hoffmann, G. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 929–939. [Google Scholar] [CrossRef]
- Bédard, A.; Tchernof, A.; Lamarche, B.; Corneau, L.; Dodin, S.; Lemieux, S. Effects of the traditional Mediterranean diet on adiponectin and leptin concentrations in men and premenopausal women: Do sex differences exist? Eur. J. Clin. Nutr. 2014, 68, 561–566. [Google Scholar] [CrossRef] [PubMed]
- Bujtor, M.; Turner, A.I.; Torres, S.J.; Esteban-Gonzalo, L.; Pariante, C.M.; Borsini, A. Associations of Dietary Intake on Biological Markers of Inflammation in Children and Adolescents: A Systematic Review. Nutrients 2021, 13, 356–385. [Google Scholar] [CrossRef]
- Soltani, S.; Chitsazi, M.J.; Salehi-Abargouei, A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: A systematic review and meta-analysis of randomized trials. Clin. Nutr. 2018, 37, 542–550. [Google Scholar] [CrossRef] [PubMed]
- Nilsson, A.; Halvardsson, P.; Kadi, F. Adherence to DASH-Style Dietary Pattern Impacts on Adiponectin and Clustered Metabolic Risk in Older Women. Nutrients 2019, 11, 805–814. [Google Scholar] [CrossRef] [Green Version]
- AlEssa, H.B.; Malik, V.S.; Yuan, C.; Willett, V.C.; Huang, T.; Hu, F.B.; Tobias, D.K. Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women. Am. J. Clin. Nutr. 2017, 105, 432–441. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Prates, R.E.; Beretta, M.V.; Nascimento, F.V.; Bernaud, F.R.; de Almeira, J.C.; Rodrigues, T.C. Saturated fatty acid intake decreases serum adiponectin levels in subjects with type 1 diabetes. Diabetes Res. Clin. Pract. 2016, 116, 205–211. [Google Scholar] [CrossRef]
- Kahleova, H.; Levin, S.; Barnard, N. Cardio-Metabolic Benefits of Plant-Based Diets. Nutrients 2017, 9, 848–861. [Google Scholar] [CrossRef]
- Ambroszkiewicz, J.; Chełchowska, M.; Rowicka, G.; Klemarczyk, W.; Strucińska, M.; Gajewska, J. Anti-Inflammatory and Pro-Inflammatory Adipokine Profiles in Children on Vegetarian and Omnivorous Diets. Nutrients 2018, 10, 1241–1254. [Google Scholar] [CrossRef] [Green Version]
- Kahleova, H.; Matoulek, M.; Malinska, H.; Oliyarnik, O.; Kazdova, L.; Neskudla, T.; Skoch, A.; Hajek, M.; Hill, M.; Kahle, M.; et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabet. Med. 2011, 28, 549–559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lovrenčić, M.V.; Gerić, M.; Kosuta, I.; Dragicević, M.; Garaj-Vrhovac, V.; Gajski, G. Sex-specific effects of vegetarian diet on adiponectin levels and insulin sensitivity in healthy non obese individuals. Nutrition 2020, 70, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Spanos, N.; Tziomalos, K.; Macut, D.; Koiou, E.; Kandaraki, E.A.; Delkos, D.; Tsourdi, E.; Panidis, D. Adipokines, Insulin Resistance and Hyperandrogenemia in Obese Patients with Polycystic Ovary Syndrome: Cross-Sectional Correlations and the Effects of Weight Loss. Obes. Facts 2012, 5, 495–504. [Google Scholar] [CrossRef]
- Menzel, J.; Biemann, R.; Longree, A.; Isermann, B.; Mai, K.; Schulze, M.B.; Abraham, K.; Weikert, C. Associations of a vegan diet with inflammatory biomarkers. Sci. Rep. 2020, 10, 1933–1939. [Google Scholar] [CrossRef]
- Ambroszkiewicz, J.; Chełkowska, M.; Szamotulska, K.; Rowicka, G.; Klemarczyk, W.; Strucińska, M.; Gajewska, J. Bone status and adipokine levels in children on vegetarian and omnivorous diets. Clin. Nutr. 2019, 38, 730–737. [Google Scholar] [CrossRef]
- Ganie, M.A.; Sahar, T.; Rashid, A.; Wani, I.A.; Nisar, S.; Sathyapalan, T.; Vishnubhatla, S.; Ramakrishnan, L.; Parvez, T.; Geer, I. Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet. Front. Endocrinol. 2019, 10, 699–710. [Google Scholar] [CrossRef] [Green Version]
- Menzel, J.; Jabakhanji, A.; Biemann, R.; Mai, K.; Abraham, K.; Weikert, C. Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers. Sci. Rep. 2020, 10, 21736–21747. [Google Scholar] [CrossRef] [PubMed]
- Eichelmann, F.; Schwingshackl, L.; Fedirko, V.; Aleksandrova, K. Effect of plant-based diets on obesity-related inflammatory profiles: A systematic review and meta- analysis of intervention trials. Obes. Rev. 2016, 17, 1067–1079. [Google Scholar] [CrossRef]
- Haghighatdoost, F.; Bellissimo, N.; Zepetnek, J.O.T.; Rouhani, M.H. Association of vegetarian diet with inflammatory biomarkers: A systematic review and meta-analysis of observational studies. Public Health Nutr. 2017, 20, 2713–2721. [Google Scholar] [CrossRef]
- Monda, V.; Polito, R.; Lovino, A.; Finaldi, A.; Valenzano, A.; Nigro, E.; Corso, G.; Sessa, F.; Asmundo, A.; Di Nunno, N.; et al. Short-Term Physiological Effects of a Very Low-Calorie Ketogenic Diet: Effects on Adiponectin Levels and Inflammatory States. Int. J. Mol. Sci. 2020, 21, 3228. [Google Scholar] [CrossRef] [PubMed]
- Bouchonville, M.; Armamento-Villareal, R.; Shah, K.; Napoli, N.; Sinacore, D.R.; Qualls, C.; Villareal, D.T. Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: Results of a randomized controlled trial. Int. J. Obes. 2014, 38, 423–431. [Google Scholar] [CrossRef] [Green Version]
- Christiansen, T.; Paulsen, S.K.; Bruun, J.M.; Ploug, T.; Pedersen, S.B.; Richelsen, B. Diet-Induced Weight Loss and Exercise Alone and in Combination Enhance the Expression of Adiponectin Receptors in Adipose Tissue and Skeletal Muscle, but Only Diet-Induced Weight Loss Enhanced Circulating Adiponectin. J. Clin. Endocrinol. Metab. 2010, 95, 911–919. [Google Scholar] [CrossRef]
- Abbenhardt, C.; McTiernan, A.; Alfano, C.M.; Wener, M.H.; Campbell, K.L.; Duggan, C.; Foster-Schubert, K.E.; Kong, A.; Toriola, A.T.; Potter, J.D.; et al. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J. Intern. Med. 2013, 274, 163–175. [Google Scholar] [CrossRef]
- Salehi-Abargouei, A.; Izadi, V.; Azadbakht, L. The Effect of Low Calorie Diet on Adiponectin Concentration: A Systematic Review and Meta- Analysis. Horm. Metab. Res. 2015, 47, 549–555. [Google Scholar] [CrossRef]
- Song, X.; Kestin, M.; Schwarz, Y.; Yang, P.; Hu, X.; Lampe, J.W.; Kratz, M. A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study. Eur. J. Nutr. 2016, 55, 237–246. [Google Scholar] [CrossRef] [PubMed]
- Becic, T.; Studenik, C. Effects of Omega-3 Supplementation on Adipocytokines in Prediabetes and Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Metab. J. 2018, 42, 101–116. [Google Scholar] [CrossRef]
- Farimani, A.R.; Hariri, M.; Azimi-Nezhad, M.; Borji, A.; Zarei, S.; Hooshmand, E. The effect of n-3 PUFAs on circulating adiponectin and leptin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2018, 55, 641–652. [Google Scholar] [CrossRef]
- Bahreini, M.; Ramezani, A.H.; Shishehbor, F.; Mansoori, A. The Effect of Omega-3 on Circulating Adiponectin in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Can. J. Diabetes 2018, 42, 553–559. [Google Scholar] [CrossRef]
- Barbosa, M.M.A.L.; de Melo, A.L.T.R.; Damasceno, N.R.T. The benefits of u-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial. Nutrition 2017, 34, 7–13. [Google Scholar] [CrossRef]
- Mazaherioun, M.; Saedisomeolia, A.; Javanbakht, M.H.; Koohdani, F.; Eshraghian, M.R.; Djalali, M. Beneficial effects of n-3 polyunsaturated fatty acids on adiponectin levels and AdipoR gene expression in patients with type 2 diabetes mellitus: A randomized, placebo-controlled, double blind clinical trial. Arch. Med. Sci. 2017, 13, 716–724. [Google Scholar] [CrossRef] [Green Version]
- Khorrami, E.; Hosseinzadeh-Attar, M.J.; Esmaillzadeh, A.; Alipoor, E.; Hosseini, M.; Emkanjou, Z.; Mohammadi, R.K.; Moradmand, S. Effect of fish oil on circulating asymmetric dimethylarginine and adiponectin in overweight or obese patients with atrial fibrillation. Food Sci. Nutr. 2020, 8, 2165–2172. [Google Scholar] [CrossRef]
- Balfegó, M.; Canivell, S.; Hanzu, F.A.; Sala-Vila, A.; Martínez-Medina, M.; Murillo, S.; Mur, T.; Ruano, E.G.; Linares, F.; Porras, N.; et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naïve patients with type 2 diabetes: A pilot randomized trial. Lipids Health Dis. 2016, 15, 78–89. [Google Scholar] [CrossRef] [Green Version]
- Song, J.; Hu, M.; Li, C.; Yang, B.; Ding, Q.; Wang, C.; Mao, L. Dose-dependent effects of fish oil on cardio- metabolic biomarkers in healthy middle-aged and elderly Chinese people: A double blind randomized controlled trial. Food Funct. 2018, 9, 3235–3243. [Google Scholar] [CrossRef] [Green Version]
- Nadjarzadeh, A.; Dehghani-Firouzabadi, R.; Daneshbodi, H.; Lotfi, M.H.; Vaziri, N.; Mozaffari-Khosravi, H. Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome. J. Reprod. Infertil. 2015, 16, 212–220. [Google Scholar]
- Mejia-Montilla, J.; Reyna-Villasmil, E.; Domínguez-Brito, L.; Naranjo-Rodríjuez, C.; Noriega-Verdugo, D.; Padilla-Samaniego, M.; Vargas-Olalla, V. Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome. Endocrinol. Diabetes Nutr. 2018, 65, 192–198. [Google Scholar] [CrossRef]
- Haidari, F.; Banaei-Jahromi, N.; Zakerkish, M.; Ahmadi, K. The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: A randomized open- labeled controlled clinical trial. Nutr. J. 2020, 19, 8–19. [Google Scholar] [CrossRef] [PubMed]
- Gomes, P.M.; Hollanda-Miranda, W.R.; Beraldo, R.A.; Castro, A.V.B.; Geloneze, B.; Foss, M.C.; Foss-Freitas, M.C. Supplementation of a-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes. Nutrition 2015, 31, 853–857. [Google Scholar] [CrossRef] [PubMed]
- Jalili, C.; Pezeshki, M.; Askarpour, M.; Marx, W.; Hassani, B.; Hadi, A.; Ghaedi, E. The effect of flaxseed supplementation on circulating adiponectin and leptin concentration in adults: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2020, 34, 1578–1586. [Google Scholar] [CrossRef] [PubMed]
- Kalgaonkar, S.; Almario, R.U.; Gurusinghe, D.; Garamendi, E.M.; Buchan, W.; Kim, K.; Karakas, S.E. Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. Eur. J. Clin. Nutr. 2011, 65, 386–393. [Google Scholar] [CrossRef] [Green Version]
- Yang, L.; Guo, Z.; Qi, S.; Fang, T.; Zhu, H.; Santos, H.O.; Khani, V.; Vong, C.H.; Qiu, Z. Walnut intake may increase circulating adiponectin and leptin levels but does not improve glycemic biomarkers: A systematic review and meta- analysis of randomized clinical trials. Complement. Ther. Med. 2020, 52, 1–7. [Google Scholar] [CrossRef]
- Kabiri, A.; Hosseinzadeh-Attar, M.J.; Haghighatdoost, F.; Eshraghian, M.; Esmaillzadeh, A. Impact of olive oil-rich diet on serum omentin and adiponectin levels: A randomized cross-over clinical trial among overweight women. Int. J. Food Sci. Nutr. 2017, 68, 560–568. [Google Scholar] [CrossRef]
- Torres-Castillo, N.; Silva-Gómez, J.A.; Campos- Perez, W.; Barron-Cabrera, E.; Hernandez-Cañaveral, I.; Garcia- Cazarin, M.; Marquez-Sandoval, Y.; Gonzalez-Becerra, K.; Barron-Gallardo, C.; Martinez-Lopez, E. High Dietary ω-6:ω-3 PUFA Ratio Is Positively Associated with Excessive Adiposity and Waist Circumference. Obes. Facts 2018, 11, 344–353. [Google Scholar] [CrossRef]
- Pereira, R.I.; Wang, C.C.L.; Wolfe, P.; Havranek, E.P.; Long, C.S.; Bessesen, D.H. Associations of Adiponectin with Adiposity, Insulin Sensitivity, and Diet in Young, Healthy, Mexican Americans and Non-Latino White Adults. Int. J. Environ. Res. Public Health 2016, 13, 54–63. [Google Scholar] [CrossRef] [Green Version]
- Qi, L.; Rimm, E.; Liu, S.; Fifai, N.; Hu, F.B. Dietary Glycemic Index, Glycemic Load, Cereal Fiber, and Plasma Adiponectin Concentration in Diabetic Men. Diabetes Care 2005, 28, 1022–1028. [Google Scholar] [CrossRef] [Green Version]
- AlEssa, H.B.; Ley, S.H.; Rosner, B.; Malik, V.S.; Willett, W.C.; Campos, H.; Hu, F.B. High Fiber and Low Starch Intakes Are Associated with Circulating Intermediate Biomarkers of Type 2 Diabetes among Women. J. Nutr. 2016, 146, 306–317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mirmiran, P.; Hosseini, S.; Hosseinpour-Niazi, S.; Azizi, F. Legume consumption increase adiponectin concentrations among type 2 diabetic patients: A randomized crossover clinical trial. Endocrinol. Diabetes Nutr. 2019, 66, 49–55. [Google Scholar] [CrossRef] [PubMed]
- Shabalala, S.C.; Dludla, P.V.; Mabasa, L.; Kappo, A.P.; Basson, A.K.; Pheiffer, C.; Johnson, R. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed. Pharmacother. 2020, 131, 1–17. [Google Scholar] [CrossRef]
- Izadi, V.; Larijani, B.; Azadbakht, L. Is Coffee and Green Tea Consumption Related to Serum Levels of Adiponectin and Leptin? Int. J. Prev. Med. 2018, 9, 106–113. [Google Scholar]
- Kempf, K.; Herder, C.; Erlund, I.; Kolb, H.; Martin, S.; Carstensen, M.; Koenig, W.; Sundvall, J.; Bidel, S.; Kuha, S.; et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: A clinical trial. Am. J. Clin. Nutr. 2010, 91, 950–957. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yamashita, K.; Yatsuya, H.; Muramatsu, T.; Toyoshima, H.; Murohara, T.; Tamakoshi, K. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: A cross-sectional study. Nutr. Diabetes 2012, 2, 33–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Williams, C.J.; Fargnoli, J.L.; Hwang, J.J.; van Dam, R.M.; Blackburn, G.L.; Hu, F.B.; Mantzoros, C.S. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: A prospective cohort study. Diabetes Care 2008, 31, 504–507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Imatoh, T.; Tanihara, S.; Miyazaki, M.; Momose, Y.; Uryu, Y.; Une, H. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur. J. Nutr. 2011, 50, 279–284. [Google Scholar] [CrossRef] [PubMed]
- Chen, I.J.; Liu, C.-Y.; Chiu, J.-P.; Hsu, C.-H. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2016, 35, 592–599. [Google Scholar] [CrossRef]
- Hsu, C.-H.; Tsai, T.-H.; Kao, Y.-H.; Hwang, K.-H.; Tseng, T.-Y.; Chou, P. Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2008, 27, 363–370. [Google Scholar] [CrossRef]
- Liu, C.-Y.; Huang, C.-J.; Huang, L.H.; Chen, I.-J.; Chiu, J.-P.; Hsu, C.-H. Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, Double-Blinded, and Placebo-Controlled Trial. PLoS ONE 2014, 9, 91163–91172. [Google Scholar] [CrossRef] [PubMed]
- Haghighatdoost, F.; Nobakht, B.F.; Hariri, M. Effect of Green Tea on Plasma Adiponectin Levels: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials. J. Am. Coll. Nutr. 2017, 36, 541–548. [Google Scholar] [CrossRef] [PubMed]
- Panahi, Y.; Hosseini, M.S.; Khalili, N.; Naimi, E.; Soflaei, S.S.; Majeed, M.; Sahebkar, A. Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition 2016, 32, 1116–1122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Campos-Cervantes, A.; Murillo-Ortiz, B.; Alvarado-Caudillo, Y.; Perez-Vazquez, V.; Ramírez-Emiliano, J. Curcumin Decreases the Oxidative Damage Indexes and Increases the Adiponectin Levels in Serum of Obese Subjects. Free Radical Biol. Med. 2011, 10, 463–475. [Google Scholar] [CrossRef]
- Mirhafez, S.R.; Farimani, A.R.; Dehhabe, M.; Bidkhori, M.; Hariri, M.; Ghouchani, B.F.N.M.; Abdollahi, F. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo Controlled Clinical Trial. J. Gastrointestin. Liver Dis. 2019, 28, 183–189. [Google Scholar] [CrossRef]
- Adibian, M.; Hodaei, H.; Nikpayam, O.; Sohrab, G.; Hekmatdoost, A.; Hedayati, M. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother. Res. 2019, 33, 1374–1383. [Google Scholar] [CrossRef] [Green Version]
- Akbari, M.; Lankarani, K.B.; Tabrizi, R.; Ghayour-Mobarhan, M.; Peymani, P.; Ferns, G.; Ghaderi, A.; Asemi, Z. The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Endocrinol. 2019, 10, 649–662. [Google Scholar] [CrossRef] [Green Version]
- Clark, C.C.T.; Ghaedi, E.; Arab, A.; Pourmasoumi, M.; Hadi, A. The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab. Syndr. 2019, 13, 2819–2825. [Google Scholar] [CrossRef] [PubMed]
- Tucakovic, L.; Colson, N.; Santhakumar, A.B.; Kundur, A.R.; Shuttleworth, M.; Singh, I. The effects of anthocyanins on body weight and expression of adipocyte’s hormones: Leptin and adiponectin. J. Funct. Foods 2018, 45, 173–180. [Google Scholar] [CrossRef]
- Yang, L.; Ling, W.; Qiu, Y.; Liu, Y.; Wang, L.; Yang, J.; Wang, C.; Ma, J. Anthocyanins increase serum adiponectin in newly diagnosed diabetes but not in prediabetes: A randomized controlled trial. Nutr. Metab. 2020, 17, 78–86. [Google Scholar] [CrossRef] [PubMed]
- Jeong, H.S.; Hong, S.J.; Lee, T.-B.; Kwon, J.-W.; Jeong, T.T.; Joo, H.J.; Park, J.H.; Ahn, C.-M.; Yu, C.W.; Lim, D.-S. Effects of Black Raspberry on Lipid Profiles and Vascular Endothelial Function in Patients with Metabolic Syndrome. Phytother. Res. 2014, 28, 1492–1498. [Google Scholar] [CrossRef]
- Tomé-Carneiro, J.; Gonzálvez, M.; Larrosa, M.; Yáñez-Gascó, M.J.; García-Almagro, F.J.; Ruiz-Ros, J.A.; Tomás-Barberán, F.A.; García-Conesa, M.T.; Espín, J.C. Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease. Cardiovasc. Drugs Ther. 2013, 27, 37–48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shahi, M.M.; Zakerzadeh, M.; Zakerkish, M.; Zarei, M.; Saki, A. Effect of Sesamin Supplementation on Glycemic Status, Inflammatory Markers, and Adiponectin Levels in Patients with Type 2 Diabetes Mellitus. J. Diet. Suppl. 2017, 14, 65–75. [Google Scholar] [CrossRef] [PubMed]
- Kim, K.-A.; Yim, J.-E. The Effect of Onion Peel Extract on Inflammatory Mediators in Korean Overweight and Obese Women. Clin. Nutr. Res. 2016, 5, 261–269. [Google Scholar] [CrossRef]
- Rezvan, N.; Moini, A.; Gorgani-Firuzjaee, S.; Hosseinzadeh-Attar, M.J. Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial. Cell J. 2018, 19, 627–633. [Google Scholar]
- Mohammadi-Sartang, M.M.; Mazloom, Z.; Sohrabi, Z.; Sherafatmanesh, S.; Barati-Boldaji, R. Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2017, 117, 394–405. [Google Scholar] [CrossRef]
- Gadotti, T.N.; Norde, M.M.; Rogero, M.M.; Fisberg, M.; Fisberg, R.M.; Oki, E.; Martini, L.A. Dairy consumption and inflammatory profile: A cross-sectional population-based study, São Paulo, Brazil. Nutrition 2018, 48, 1–5. [Google Scholar] [CrossRef]
- Bahari, T.; Uemura, H.; Katsuura-Kamano, S.; Yamaguchi, M.; Nakamoto, M.; Miki, K.; Sawachika, F.; Arisawa, K. Association between dietary patterns and serum adiponectin: A cross-sectional study in a Japanese population. Int. J. Food Sci. Nutr. 2018, 69, 205–214. [Google Scholar] [CrossRef] [PubMed]
- Yannakoulia, M.; Yiannakouris, N.; Melistas, L.; Kontogianni, M.D.; Malagaris, I.; Mantzoros, C.S. A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metab. Clin. Exp. 2008, 57, 824–830. [Google Scholar] [CrossRef] [PubMed]
- Niu, K.; Kobayashi, Y.; Guan, L.; Monma, H.; Guo, H.; Cui, Y.; Otomo, A.; Chujo, M.; Nagatomi, R. Low-fat dairy, but not whole-/high-fat dairy, consumption is related with higher serum adiponectin levels in apparently healthy adults. Eur. J. Nutr. 2013, 52, 771–778. [Google Scholar] [CrossRef] [PubMed]
- Bell, S.; Britton, A. The Role of Alcohol Consumption in Regulating Circulating Levels of Adiponectin: A Prospective Cohort Study. J. Clin. Endocrinol. Metab. 2015, 100, 2763–2768. [Google Scholar] [CrossRef]
- Beulens, J.W.J.; van Loon, L.J.C.; Kok, F.J.; Pelsers, M.; Bobbert, T.; Spranger, J.; Helander, A.; Hendriks, H.F.J. The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: A human intervention study. Diabetologia 2007, 50, 1388–1392. [Google Scholar] [CrossRef] [Green Version]
- Nova, E.; Mauro-Martín, I.S.; Díaz-Prieto, L.E.; Marcos, A. Wine and beer within a moderate alcohol intake is associated with higher levels of HDL-c and adiponectin. Nutr. Res. 2019, 63, 42–50. [Google Scholar] [CrossRef] [Green Version]
- Jung, S.K.; Kim, M.K.; Choi, B.Y. A cross-sectional analysis of the relationship between daily alcohol consumption and serum adiponectin levels among adults aged 40 years or more in a rural area of Korea. Eur. J. Clin. Nutr. 2013, 67, 841–847. [Google Scholar] [CrossRef]
- Makita, S.; Abiko, A.; Nagai, M.; Yonezawa, S.; Koshiyama, M.; Ohta, M.; Nakamura, M. Influence of daily alcohol consumption on serum adiponectin levels in men. Metab. Clin. Exp. 2013, 62, 411–416. [Google Scholar] [CrossRef]
- Nishise, Y.; Saito, T.; Makino, N.; Okumoto, K.; Ito, J.-I.; Watanabe, H.; Saito, K.; Togashi, H.; Ikeda, C.; Kubota, I.; et al. Relationship between Alcohol Consumption and Serum Adiponectin Levels: The Takahata Study—A Cross-Sectional Study of a Healthy Japanese Population. J. Clin. Endocrinol. Metab. 2010, 95, 3828–3835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steiner, J.L.; Lang, C.H. Alcohol, Adipose Tissue and Lipid Dysregulation. Biomolecules 2017, 7, 16–40. [Google Scholar] [CrossRef] [PubMed]
- Jafari-Vayghan, H.; Tarighat-Esfanjani, A.; Jafarabadi, M.A.; Ebrahimi-Mameghan, M.; Lalezadeh, G.Z.S.S. Association Between Dietary Patterns and Serum Leptin-to-Adiponectin Ratio in Apparently Healthy Adults. J. Am. Coll. Nutr. 2015, 34, 49–55. [Google Scholar] [CrossRef]
- Norde, M.M.; Collese, T.S.; Giovannucci, E.; Rogero, M.M. A posteriori dietary patterns and their association with systemic low-grade inflammation in adults: A systematic review and meta-analysis. Nutr. Rev. 2021, 79, 331–350. [Google Scholar] [CrossRef] [PubMed]
- Alves-Santos, N.H.; Cocate, P.G.; Eshriqui, I.; Benaim, C.; Barros, E.G.; Emmett, P.M.; Kac, G. Dietary patterns and their association with adiponectin and leptin concentrations throughout pregnancy: A prospective cohort. Br. J. Nutr. 2018, 119, 320–329. [Google Scholar] [CrossRef] [Green Version]
- Ruth, M.R.; Port, A.M.; Shah, M.; Bourland, A.C.; Istfan, N.W.; Nelson, K.P.; Gokce, N.; Apovian, C.M. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein and raises serum adiponectin and high density lipoprotein-cholesterol in obese Subjects. Metabolism 2013, 62, 1–17. [Google Scholar] [CrossRef] [Green Version]
- Rajaie, S.; Azadbakht, L.; Saneei, P.; Khazaei, M.; Esmaillzadeh, A. Comparative Effects of Carbohydrate versus Fat Restriction on Serum Levels of Adipocytokines, Markers of Inflammation, and Endothelial Function among Women with the Metabolic Syndrome: A Randomized Cross-Over Clinical Trial. Ann. Nutr. Metab. 2013, 63, 159–167. [Google Scholar] [CrossRef] [PubMed]
- Kasim-Karakas, S.E.; Tsodikov, A.; Singh, U.; Jialal, I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: Effects of energy intake. Am. J. Clin. Nutr. 2006, 83, 774–779. [Google Scholar] [CrossRef] [PubMed]
- Murillo-Ortiz, B.; Martínez-Garza, S.; Landeros, V.C.; Velázquez, G.C.; García, D.S. Effect of reduced dietary fat on estradiol, adiponectin, and igF-1 levels in postmenopausal women with breast cancer. Breast Cancer 2017, 9, 359–364. [Google Scholar] [CrossRef] [Green Version]
- Cerman, A.A.; Aktaş, E.; Altunay, I.K.; Arıcı, J.E.; Tulunay, A.; Ozturk, F.Y. Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris. J. Am. Acad. Dermatol. 2016, 75, 155–162. [Google Scholar] [CrossRef]
- Loh, B.-I.; Sathyasurya, D.R.; Mohamed, H.J.J. Plasma adiponectin concentrations are associated with dietary glycémie index in Malaysian patients with type 2 diabetes. Asia Pac. J. Clin. Nutr. 2013, 22, 241–248. [Google Scholar]
- Lepsch, J.; FariaS, D.R.; Vaz, A.S.; Pinto, T.J.P.; Lima, N.S.; Vilela, A.A.F.; Cunha, M.; Factor-Litvak, P.; Kac, G. Serum saturated fatty acid decreases plasma adiponectin and increases leptin throughout pregnancy independently of BMI. Nutrition 2016, 32, 740–747. [Google Scholar] [CrossRef]
- Haidari, F.; Mohammadshahi, M.; Borsi, S.H.; Haghighizadeh, M.-H.; Malgard, S. Comparison of Essential Fatty Acid Intakes and Serum Levels of Inflammatory Factors between Asthmatic and Healthy Adults: A Case-Control Study. Iran J. Allergy Asthma 2014, 13, 335–342. [Google Scholar]
- Rezvani, R.; Cianflone, K.; McGahan, J.P.; Berglund, L.; Bremer, A.A.; Keim, N.L.; Griffen, S.C.; Havel, P.J.; Stanhope, K.L. Effects of Sugar-Sweetened Beverages on Plasma Acylation Stimulating Protein, Leptin and Adiponectin: Relationships with Metabolic Outcomes. Obesity 2013, 21, 2471–2480. [Google Scholar] [CrossRef] [Green Version]
- Pollock, N.K.; Bundy, V.; Kanto, W.; Davis, C.L.; Bernard, P.J.; Zhu, H.; Gutin, B.; Dong, Y. Greater Fructose Consumption Is Associated with Cardiometabolic Risk Markers and Visceral Adiposity in Adolescents. J. Nutr. 2012, 142, 251–257. [Google Scholar] [CrossRef]
- Magalhaes, G.C.B.; Feitoza, F.M.; Moreira, S.B.; Carmo, A.V.; Souto, F.J.D.; Reis, S.R.L.; Martins, M.S.F.; Gomes da Silva, M.H.G. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods. J. Hum. Nutr. Diet. 2014, 27, 301–312. [Google Scholar] [CrossRef] [PubMed]
- Chai, W.; Morimoto, Y.; Cooney, R.V.; Franke, A.A.; Shvetsov, Y.B.; Marchand, L.L.; Haiman, C.A.; Kolonel, L.N.; Goodman & Gertraud Maskarinec, M.T. Dietary Red and Processed Meat Intake and Markers of Adiposity and Inflammation: The Multiethnic Cohort Study. J. Am. Coll. Nutr. 2017, 36, 378–385. [Google Scholar] [CrossRef] [PubMed]
- Ley, S.H.; Sun, Q.; Willett, V.C.; Eliassen, A.H.; Wu, K.; Pan, A.; Grodstein, F.; Hu, F.B. Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am. J. Clin. Nutr. 2014, 99, 352–360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Author/Reference | Year | Study Design | Sample | Results |
---|---|---|---|---|
HEALTHY DIET | ||||
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Total AD concentration was 24% higher (15.68 ± 1.03 μg/mL vs. 12.61 ± 1.03 μg/mL; p < 0.0001) and HMW AD was 32% higher (5.71 ± 1.04 μg/mL vs. 4.34 ± 1.04 μg/mL; p < 0.0001) in women from the highest quartile of adherence to AHEI compared to women from the lowest quartile. |
Volp et al. [14] | 2016 | Cross-sectional study | 157 apparently healthy men and women, aged 18–35 y | A correlation between the Healthy Eating Index and AD concentrations (r = 0.20074; p = 0.02). |
THE MEDITERRANEAN DIET | ||||
Mantzoros et al. [17] | 2006 | Cross-sectional study | 987 diabetic women, aged 30–55 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence (6.91 ± 1.06 μg/mL vs. 5.49 ± 1.04 μg/mL; p < 0.01). |
Fragopoulou et al. [5] | 2010 | Cross-sectional study | 532 men and women free of CVD, aged > 18 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence (4.8 ± 2.0 μg/mL vs. 3.4 ± 1.9 μg/mL; p < 0.001). A correlation between scores obtained for the MD and AD concentrations (women: rho = 0.156; p = 0.02), (men: rho = 0.130; p = 0.02). |
Schwingshackl et al. [21] | 2014 | A systematic review and meta-analysis of 17 interventional studies | 2300 men and women, aged 25–77 y | Adherence to the rules of the MD was related to significantly higher AD concentrations compared to the control diet (WMD: 1.69 mg/mL, 95% CI 0.27, 3.11; p = 0.02). |
Maiorino et al. [15] | 2016 | Randomized control study | 215 men and women with newly diagnosed T2DM, aged > 18 y | Following the MD for a year was associated with an increase in total AD concentrations by 43% (6.12 vs. 8.80 μg/mL; p < 0.001) and HMV AD by 54% (2.41 vs. 3.72 μg/mL; p < 0.01). |
Sureda et al. [16] | 2018 | Cross-sectional study | 598 men and women, aged 12–65 y | Adherence to the rules of the MD was related to significantly higher AD concentrations compared to non-adherence 13.1 ± 6.7 μg/mL vs. 9.5 ± 2.4 μg/mL; p < 0.05). No correlation found in women and adolescents of both sexes. |
Spadafranca et al. [20] | 2018 | Cohort study | 99 normal weight, pregnant women, aged 25–43 y | Women from the highest tertile of adhering to the MD were characterized by a lower decrease in the percentage of AD concentrations compared to women from the lowest tertile (10% ± 11% vs. −34% ± 3%; p = 0.01). |
Luisi et al. [19] | 2019 | Interventional study | 36 men and women, aged > 18 y | Following the MD enhanced with 40 g/d of extra virgin olive oil was associated with increased AD concentrations (increase by 0.6 ± 0.26 μg/mL; p < 0.01 in a group with normal body weight and an increase by 1.6 ± 0.2 μg/mL; p < 0.01 in a group with excessive body weight). |
Kouvari et al. [18] | 2020 | Prospective cohort study | 3042 apparently healthy men and women, aged > 18 y | Higher adherence to the MD was associated with markedly higher AD concentrations compared to the lowest adherence 4.8 ± 2.0 μg/mL vs. 3.4 ± 1.9 μg/mL; p < 0.001) |
THE DASH DIET | ||||
Nilsson et al. [25] | 2019 | Cross-sectional study | 112 women, aged 65–70 y | The highest tertile of adherence to the DASH diet was associated with markedly higher AD concentrations compared to the lowest tertile (12.9 ± 3.3 μg/mL vs. 11.5 ± 3.4 μg/mL; p = 0.008). |
PLANT-BASED DIET | ||||
Kahleova et al. [30] | 2011 | Randomized control study | 74 men and women with T2DM, aged 30–70 y | An increase in total AD by 19% (95% CI 7.5–25.4; p < 0.05) and HMV AD by 15% (95% CI 3.6–23.6; p < 0.05) after 24 weeks of following a vegetarian diet. |
Ambroszkiewicz et al. [29] | 2018 | Cross-sectional study | 117 prepubertal children, aged 5–10 y | Following a vegetarian diet was associated with a significantly higher adiponectin to leptin ratio (0.70 (0.37–0.93) vs. 0.39 (0.28–0.74); p = 0.005) compared to the traditional diet. |
Mirmiran et al. [65] | 2019 | Randomized cross-over clinical trial | 31 men and women with T2DM, aged 50–75 y | The consumption of two servings of pulses instead of red meat for eight weeks was associated with an increase in AD concentrations (10.5 ± 3.0 μg/mL vs. 13.1 ± 3.0 μg/mL; p < 0.05). |
Lovrenčić et al. [31] | 2020 | Case-control study | 76 non-obese men and women, aged 19–59 | Following a vegetarian diet was associated with significantly higher AD concentrations compared to the traditional diet (p = 0.03). No correlation in men. |
LOW-CALORIE DIET | ||||
Christiansen et al. [41] | 2010 | Randomized controlled trial | 79 obese men and women, aged 18–45 y | VLCD diet (800 kcal/d) was associated with a 19% increase in AD concentrations after 12 weeks (p < 0.01). |
Abbenhardt et al. [42] | 2013 | Randomized controlled trial | 439 overweight or obese postmenopausal women, aged 50–75 y | AD concentrations increased by 9.5% after 12 months of following LCD (12.4 μg/mL (11.3–13.5) vs. 13.5 μg/mL (12.5–14.6); p < 0.0001) and by 6.6% (12.8 μg/mL (11.7–13.9) vs. 13.6 μg/mL (12.5–14.8); p = 0.0001) as a result of combining LCD with physical activity. |
Bouchonville et al. [40] | 2014 | Randomized controlled trial | 107 obese men and women, aged ≥65 y | Calorie reduction of the diet by 500–700 kcal contributed to an increase in AD concentration by 8.9 μg/mL (3.5–14.8); p < 0.01), while the combination of reduction diet and physical activity contributed to an AD increase by 6.5 μg/mL (0.8–12.3; p = 0.02). |
Salehi-Abargouei et al. [43] | 2015 | Systematic review and meta-analysis of interventional trials (13 interventional studies) | 937 men and women, aged 20–75 y | The use of LCD was associated with an increase in AD concentration (Hedges’ g = 0.34, 95 % CI 0.17–0.50; p < 0.001), especially if the diet was followed for at least 16 weeks (Hedges’ g for ≤ 16 weeks = 0.48, 95% CI: 0.12–0.83; p = 0.01, (Hedges’ g for > 6 weeks = 0.30, 95 % CI: 0.11–0.48; p = 0.002). |
Monda et al. [39] | 2020 | Interventional study | 20 obese men and women, aged 20–60 y | The use of ketogenic VLCD for 8 weeks was associated with a significant increase in AD concentrations both in women (12.44 ± 1.07 μg/mL vs. 27.3 ± 1.33 μg/mL; p < 0.05), and in men (9.23 ± 0.7 μg/mL vs. 32.67 ± 1.6 μg/mL; p < 0.05). |
POLYUNSATURATED FATTY ACIDS | ||||
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women, free of CVD, diabetes and cancer, aged 30–55 y | Women from the group characterized by the lowest ratio of PUFA to SFA consumption had significantly higher total AD (12.66 ± 1.03 μg/mL vs. 11.47 ± 1.03 μg/mL; p = 0.01) and HMW (4.19 ± 1.04 μg/mL vs. 3.60 ± 1.03 μg/mL; p = 0.005) compared to women with the highest ratio. |
Kalgaonkar et al. [58] | 2011 | Randomized, prospective study | 36 women with PCOS, aged 20–45 y | The consumption of walnuts and almonds significantly increased AD concentrations (walnuts: 9.5 ± 1.6 μg/mL vs. 11.3 ± 1.8 μg/mL; p = 0.0241; almonds: 10.1 ± 1.5 μg/mL vs. 12.2 ± 1.4 μg/mL; p = 0.0262). |
Nadjarzadeh et al. [53] | 2015 | Randomized double-blind placebo-controlled clinical trial. | 84 women with polycystic ovary syndrome, aged > 18 y | Omega-3 supplementation (180 mg EPA and 120 mg DHA) for eight weeks significantly increased AD concentrations (4.44 ± 1.92 μg/mL vs. 5.62 ± 2.68 μg/mL; p < 0.005). |
Gomes et al. [56] | 2015 | Randomized double-blind, placebo-controlled trail | 20 men and women with T2DM, aged 30–65 y | Supplementation with 3 g of ALA increased AD concentrations after 60 days (10.61 ± 6.53 μg/mL vs. 15.01 ± 11.68 μg/mL; p = 0.01). |
Balfegó et al. [51] | 2016 | Pilot randomized trial | 35 men and women with T2DM, aged 40–70 y | Introducing 10 g of sardines into the diet (five times a week for six months) was associated with a significant increase in AD concentrations (2.1 ± 0.3 μg/mL vs. 3.0 ± 0.3 μg/mL; p = 0.04) |
Barbosa et al. [48] | 2017 | Randomized, double-blind placebo-controlled clinical trial | 80 men and women with at least one cardiovascular risk factor, aged 30–74 y | Omega-3 supplementation (3 g/d) for two months significantly increased AD concentrations (14.8 ± 10.0 μg/mL vs. 18.2 ± 12.1 μg/mL; p = 0.021). |
Mazaherioun et al. [49] | 2017 | Randomized, placebo-controlled, double-blind clinical trial | 88 men and women with T2DM, aged 30–65 y | Omega-3 supplementation (2.7 g/d) significantly increased AD concentrations (5.09 ± 2.79 μg/mL vs. 5.58 ± 3.13 μg/mL; p < 0.001). |
Mejia-Montilla et al. [54] | 2018 | Prospective study | 195 women with PCOS, aged > 18 y | N-3 supplementation (180 mg EPA and 120 mg DHA) significantly increased AD concentrations (3.9 ± 1.1 μg/mL vs. 5.3 ± 1.4 μg/mL; p = 0.001), both in women with HOMA-IR <3.5 (3.9 ± 1.1 μg/mL vs. 5.3 ± 1.4 μg/mL; p < 0.0001), and in those with HOMA-IR >3.5 (4.1 ± 1.1 μg/mL vs. 5.6 ± 1.3 μg/mL; p = 0.005). |
Song et al. [52] | 2018 | Double-blind randomized controlled trial | 201 healthy men and women, aged > 40 y | An increase in AD concentrations over 12 weeks as a result of omega-3 supplementation at a dose of: 3.1 g/d (5.79 ± 2.68 μg/mL vs. 6.36 ± 2.64 μg/mL; p < 0.05), 6.2 g/d (5.72 ± 2.07 μg/mL vs. 6.87 ± 2.58 μg/mL; p < 0.01) and 12.4 g/d (5.81 ± 2.13 μg/mL vs. 7.43 ± 2.63 μg/mL; p < 0.01). |
Bahreini et al. [47] | 2018 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 177 men and women with T2DM, aged > 18 y | An increase in AD concentrations by 0.57 μg/mL as a result of omega-3 supplementation (95% CI 0.15–1.31; p = 0.01). |
Becic et al. [45] | 2018 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 460 men and women with prediabetes and T2DM, aged > 18 y | An increase in AD concentrations by 0.48 μg/mL as a result of omega-3 supplementation (95% Cl 0.27–0.68; p < 0.00001). |
Haidari et al. [55] | 2020 | Randomized open-labeled controlled clinical trial | 41 women with PCOS, aged 18–45 y | An increase in AD concentrations over 12 weeks as a result of supplementation with 30 g of ground linseed (13.04 ± 3.36 μg/mL vs. 17.36 ± 4.1 μg/mL; p = 0.002). |
Khorrami et al. [50] | 2020 | Randomized double-blind, placebo-controlled study | 80 overweight or obese men and women with atrial fibrillation, aged > 50 y | An increase in AD concentrations over eight weeks as a result of supplementation with 2 g/d of fish oil (11.88 ± 6.94 μg/mL vs. 13.15 ± 7.33 μg/mL; p = 0.026). |
Yang et al. [59] | 2020 | A systematic review and meta-analysis of randomized clinical trials (3 randomized controlled trails) | 823 men and women, aged > 18 y | The consumption of walnuts significantly increased AD concentrations (WMD: 0.440 μg/mL; 95% CI: 0.323 to 0.557; p < 0.001). |
DIETARY FIBER | ||||
Qi et al. [63] | 2005 | Cross-sectional study | 780 men with T2DM, aged 40–75 y | Men from the highest quartile of dietary fiber consumption had significantly higher AD concentrations compared to men from the lowest quartile (17.3 μg/mL vs. 14.2 μg/mL; p = 0.006). |
Mantzoros et al. [17] | 2006 | Cross-sectional study | 987 diabetic women, aged 30–55 y | The consumption of whole-grain cereal products was associated with significantly higher AD concentrations (6.11 ± 1.06 μg/mL vs. 4.92 ± 1.05 μg/mL; p < 0.01). |
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of cereal fiber consumption were characterized by significantly higher total AD concentrations (14.73 ± 1.03 μg/mL vs. 13.36 ± 1.04 μg/mL; p < 0.04) and AD HMW (5.32 ± 1.04 μg/mL vs. 4.56 ± 1.04 μg/mL; p < 0.02) compared to women from the lowest quartile. |
Pereira et al. [62] | 2016 | Observational, cross-sectional study | 43 men and women, 18–60 y | A higher consumption of fiber included in vegetables and fruit was associated with higher AD concentrations (r = 0.50; p = 0.0007). The concentrations of adiponectin were 4.7 μg/mL (p = 0.03) higher in individuals from the highest quartile of cereal fiber consumption compared to participants from the lowest quartile. |
AlEssa et al. [64] | 2016 | Cross-sectional study | 2458 women, free of diabetes, aged 43–70 y | Women from the highest quintile of total fiber (p < 0.001), cereal fiber (p < 0.001), fruit fiber (p = 0.014) and vegetable fiber (p = 0.011) consumption had significantly higher AD concentrations compared to women from the lowest quintile. |
CURCUMIN | ||||
Campos-Cervantes et al. [77] | 2011 | Randomized, single blind, placebo-controlled trial | 50 obese men, aged 25–30 y | An increase in AD concentrations after six and 12 weeks of supplementation with 500 mg of curcumin (after six weeks: 16.0 μg/mL vs. 18.5 μg/mL; p < 0.01 and after 12 weeks: 16.0 μg/mL vs. 18. μg/mL; p < 0.02). |
Panahi et al. [76] | 2016 | Randomized controlled trial | 117 men and women, aged > 18 y | An increase in AD concentrations after eight weeks of supplementation with 1000 mg of curcumin (12.67 ± 2.13 μg/mL vs. 21.28 ± 4.40 μg/mL; p < 0.001). |
Mirhafez et al. [78] | 2019 | Randomized, double blind, placebo-controlled, cross-over trial | 65 men and women with nonalcoholic fatty liver disease, aged > 18 y | Supplementation with 250 mg/d of curcumin for wight weeks caused a significant increase in AD concentrations (14.35 ± 7.72 μg/mL vs. 18.23 ± 9.75 μg/mL; p < 0.001). |
Adibian et al. [79] | 2019 | Randomized, double blind, placebo-controlled trial | 44 men and women with T2DM, aged 40–70 y | Supplementation with 1500 mg/d of curcumin for 10 weeks caused a significant increase in AD concentrations (52.0 ± 8.0 μg/mL vs. 64.0 ± 3.0 μg/mL; p < 0.0001). |
Clark et al. [81] | 2019 | A systematic review and meta-analysis of interventional trials (10 randomized controlled trails) | 652 men and women with type 2 diabetes, prediabetes subjects, obese men or with metabolic syndrome, aged 18–84 y | Supplementation with curcumin caused a significant increase in AD concentrations compared to placebo (WMD: 0.82 Hedges’ g; 95% CI 0.33–1.30; p˂0.001). A particularly beneficial effect of at least 10 weeks of supplementation (WMD: 1.05 Hedges’ g; 95% CI: 0.64 to 1.45; p ˂ 0.001). |
Akbari et al. [80] | 2019 | Systematic review and meta-analysis of randomized controlled trials (21 randomized controlled trails) | 1646 men and women with metabolic syndrome | An increase in AD concentrations after supplementation with curcumin (SMD 1.05; 95% CI 0.23–1.87; p = 0.01). |
ANTHOCYANINS | ||||
Jeong et al. [84] | 2014 | Prospective randomized double-blind study | 77 men and women with metabolic syndrome, aged 18–75 y | Daily black raspberry consumption for 12 weeks was associated with an increase in AD concentrations (5.7 ± 5.1 μg/mL vs. 7.7 ± 5.0 μg/mL; p < 0.05). |
Tucakovic et al. [82] | 2018 | Randomized, double-blind, placebo-controlled, cross-over trial | 20 apparently healthy men and women, aged 18–65 y | Supplementation with the Queen Garnet plum for four weeks increased AD concentrations by the average of 3.83 μg/mL (p = 0.048). |
Yang et al. [83] | 2020 | Randomized controlled trial | 160 men and women with T2DM or prediabetes | Anthocyanin supplementation for 12 weeks was associated with an increase in AD concentrations compared to placebo (increase by 0.46 μg/mL; p = 0.038). |
RESVERATROL | ||||
Tomé-Carneiro et al. [85] | 2013 | Triple-blind, placebo-controlled clinical trial | 75 men and women, aged > 18 y | Supplementation with grape extract for six months increased AD concentrations by 9.6% (p = 0.01). |
Mohammadi-Sartang et al. [89] | 2017 | Systematic review and meta-analysis of randomized controlled trials (9 randomized controlled trails) | 590 men and women, aged > 18 y | Resveratrol supplementation significantly increased AD concentrations (WMD: 1.10 μg/mL, 95% CI 0.88, 1.33; p < 0.001) |
QUERCETIN | ||||
Kim et al. [87] | 2016 | Randomized double-blind, placebo-controlled study | 37 healthy overweight and obese women | AD increase after 12 weeks of quercetin supplementation (3.6 ± 2.0 μg/mL vs. 6.9 ± 2.3 μg/mL; p < 0.05). |
Rezvan et al. [88] | 2018 | Randomized double-blind, placebo-controlled study | 81 women with PCOS, aged 20–40 y | An increased expression of the AD receptors (AdipoR1 and AdipoR2) after 12 weeks of supplementation with 1 g/d of quercetin (p < 0.01). |
LIGNANS | ||||
Shahi et al. [86] | 2017 | Randomized double-blind, placebo-controlled study | 48 men and women with T2DM, aged 30–60 y | AD increase after eight weeks of supplementation with 200 mg/d of sesamin (6.21 ± 1.33 μg/mL vs. 7.34 ± 2.88 μg/mL; p = 0.024). |
COFFEE | ||||
Williams et al. [70] | 2008 | Prospective cohort study | 982 women with T2DM and 1058 nondiabetic women | The consumption of ≥4 cups of coffee daily was associated with significantly higher AD compared to the consumption of <1 cup a week (women with T2DM: 7.7 vs. 6.1 μg/mL; p = 0.002, nondiabetic women: 15.0 vs. 13.2 μg/mL; p = 0.04). |
Kempf et al. [68] | 2010 | Single-blind clinical trial | 47 men and women, free of T2DM, aged 18–65 y | The consumption of eight cups of coffee daily was associated with significantly higher AD concentrations compared to consuming no coffee (8421 (6634–11256) ng/mL vs. 7957 (6317, 10901) ng/mL; p < 0.05). |
Imatoh et al. [71] | 2011 | Cross-sectional study | 665 men, aged > 18 y | The consumption of ≥3 cups of coffee daily was associated with significantly higher AD compared to consuming no coffee (6.9 ± 3.3 μg/mL vs. 6.0 ± 2.6 μg/mL; p < 0.01). |
Yamashita et al. [69] | 2012 | Cross-sectional study | 3317 men and women, aged 35–69 y | The consumption of ≥4 cups of coffee daily was associated with significantly higher AD compared to the consumption of <1 cup a week (7.23 (6.84–7.65) μg/mL vs. 6.58 (6.40–6.76) μg/mL; p = 0.005). |
GREEN TEA | ||||
Hsu et al. [73] | 2008 | Randomized, double-blind, placebo-controlled clinical trial | 78 obese women, aged 16–60 y | An increase in AD concentrations after 12 weeks of supplementation with 400 mg of green tea extract (18.9 ± 6.7 μg/mL vs. 21.4 ± 8.7 μg/mL; p < 0.01). |
Fragopoulou et al. [5] | 2010 | Cross-sectional study | 532 men and women free of CVD, aged > 18 y | A correlation was found between green tea consumption and AD concentrations (rho = 0.108; p = 0.04). |
Liu et al. [74] | 2014 | Randomized, double-blind, and placebo-controlled trial | 102 men and women with T2DM, aged 20–65 y | An increase in AD concentrations after 16 weeks of supplementation with 500 mg of green tea extract (20.2 ± 5.1 μg/mL vs. 21.7 ± 5.1 μg/mL; p < 0.046). |
Chen et al. [72] | 2016 | Randomized, double-blind trial | 92 obese women, aged 20–60 y | An increase in AD concentrations after 12 weeks of supplementation with 856.8 mg of green tea extract (20.9 ± 11.0 μg/mL vs. 24.0 ± 10.7 μg/mL; p = 0.009). |
DAIRY PRODUCTS | ||||
Yannakoulia et al. [92] | 2008 | Cross-sectional study | 196 apparently healthy women, aged 18–84 y | A correlation occurred between AD and a dietary pattern rich in low-fat dairy and whole-grain cereal products (r = 0.15; p = 0.04). |
Niu et al. [93] | 2013 | Cross-sectional one-year longitudinal study | 938 apparently healthy men and women, aged > 18 y | The consumption of low-fat milk products (58.9–375 g/d) was associated with significantly higher AD concentrations compared to no consumption of such products (8.3 (7.8, 8.9) μg/mL vs. 7.3 (6.9, 7.6) μg/mL; p < 0.01). |
Fragopoulou et al. [5] | 2010 | Cross-sectional study | 532 man and women free of CVD, aged > 18 y | A correlation occurred between the consumption of low-fat milk products and AD concentrations (rho = 0.119, p = 0.04). |
Bahari et al. [91] | 2018 | Cross-sectional study | 612 men and women, 35–69 y | A diet characterized by the higher consumption of milk products was associated with higher AD concentrations (4.78 (3.24, 7.38) μg/mL vs. 3.68 (2.42, 6.12) μg/mL; p = 0.004). |
ALCOHOL | ||||
Pischon et al. [12] | 2005 | Prospective cohort study | 532 men, aged 40–75 y | Men from the highest quintile of AD concentrations (>24.9 μg/mL) consumed significantly more alcohol (16.2 ± 1.06 g/d vs. 13.05 ± 0.7 g/d) compared to men from the lowest quintile of AD concentrations (<10.6 μg/mL); p = 0.006). A correlation occurred between AD concentrations and alcohol consumption (r = 0.14; p = 0.002). |
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Total AD concentrations were 28% higher (16.01 ± 1.03 vs. 12.50 ± 1.03; p < 0.0001) and HMW AD concentrations were 45% higher (6.10 ± 1.04 vs. 4.21 ± 1.03; p < 0.0001) in women from the highest quintile of alcohol consumption compared to those who consumed no alcohol. |
Beulens et al. [95] | 2007 | Randomized, controlled, cross-over trial | 17 apparently healthy men, aged 18–40 y | Moderate alcohol consumption (32 g/d) for four weeks caused an increase in total AD concentrations by 12.5% (p < 0.001). |
Bell et al. [94] | 2015 | Prospective cohort study | 2855 men and women, aged 40–63 y | Alcohol consumption was cross-sectionally associated with AD concentrations (β = 0.003; p < 0.001). |
Nova et al. [96] | 2019 | Observational cross-sectional study | 240 men and women, aged 55–85 y | Wine consumption was associated with higher AD (β = 204, 95% CI: 37–370; p = 0.017). |
Author/Reference | Year | Study Design | Sample | Results |
---|---|---|---|---|
THE WESTERN DIET | ||||
Jafari-Vayghan et al. [101] | 2015 | Cross-sectional study | 150 apparently healthy men and women, aged 25–50 y | Adherence to the Western dietary pattern was negatively correlated with AD concentrations (r = −0.19; p = 0.02). |
Alves-Santos et al. [103] | 2018 | Prospective cohort study | 173 pregnant women free of infectious and chronic diseases, aged 20–40 y | Adherence to the Western dietary pattern was negatively correlated with AD concentrations during pregnancy (high vs. low tertile of adherence: β = −1.11; 95% CI −2.00, −0.22; p < 0.05). |
HIGH-CARBOHYDRATE LOW-FAT DIET | ||||
Pischon et al. [12] | 2005 | Prospective cohort study | 532 men, aged 40–75 y | A 5% increase in energy obtained from carbohydrates instead of lipids was associated with reduction in AD concentrations by 0.59 μg/mL (p = 0.05). |
Kasim-Karakas et al. [106] | 2006 | Interventional study | 22 healthy postmenopausal women, aged > 50 y | Following the eucaloric LFHC diet was linked to a reduction in AD concentrations (16.3 ± 2.1 μg/mL to 14.2 ± 2.0 μg/mL; p < 0.05). |
Rajaie et al. [105] | 2013 | Randomized cross-over clinical trial | 30 overweight or obese women with metabol ic syndrome, aged 20–65 y | Following HCD for 6 weeks was linked to AD concentration reduction by 1.68 ± 2.30 μg/mL (10.6 ± 0.3 μg/mL vs. 8.9 ± 0.3 μg/mL; p < 0.001). |
Ruth et al. [104] | 2013 | Randomized clinical trial | 55 obese men and women, aged 21–62 y | Following an HFLC diet for 12 weeks was related to a significant increase in AD concentrations (+0.40 ± 0.66 μg/mL, p = 0.045). |
Song et al. [43] | 2016 | Randomized controlled interventional study | 93 women and men aged 21–76 years | AD decreased by 9.4% (p = 0.008) in individuals following an LFHC diet compared to those following a diet with a moderate fat content. |
Murillo-Ortiz et al. [107] | 2017 | Randomized controlled clinical trial | 100 postmenopausal women with breast cancer, aged >48 y | Following a diet with the reduced fat content (12% of energy) for 6 months was associated with reduced AD concentrations (21.23 ± 14.32 μg/mL vs. 16.05 ± 10.25 μg/mL; p < 0.001). |
Meshkini et al. [11] | 2018 | Cross-sectional study | 89 apparently healthy men and women, aged 18–75 y | AD concentrations were negatively correlated with the amount of carbohydrates in the diet (r = −0.24, p = 0.02). |
GLYCEMIC INDEX AND GLYCEMIC LOAD OF THE DIET | ||||
Qi et al. [63] | 2005 | Cross-sectional study | 780 men with T2DM, aged 40–75 y | AD concentrations significantly lower in the highest quintile of the GI of the diet compared to the lowest GI (14.3 μg/mL vs. 16.4 μg/mL; p = 0.005). AD concentrations significantly lower in the highest quintile of the GL of the diet compared to the lowest GL (14.1 μg/mL vs. 17.2 μg/mL; p = 0.004). |
Pischon et al. [12] | 2005 | Prospective cohort study | 532 men, aged 40–75 y | Men from the highest quintile of AD concentrations (>24.9 μg/mL) were characterized by a significantly higher GL of the diet (124.7 ± 2.1 vs. 128.5 ± 1.0; p = 0.04) compared to men from the lowest quintile of AD concentrations (<10.6 μg/mL); p = 0.006). Each GL increment by 1 unit was associated with AD reduction by 1.32 μg/mL (p = 0.02). |
Loh et al. [109] | 2013 | Cross-sectional study | 305 T2DM men and women, aged 19–75 y | A negative correlation between the GI of the diet and AD concentrations (β = −0.272, 95% CI −0.262–0.094; p < 0.001). |
Cerman at tal. [108] | 2016 | Cross-sectional study | 86 men and women apparently healthy or with acne vulgaris, aged > 18 y | A negative correlation between the GI of the diet and AD concentrations (r = −0.212; p = 0.049). |
Pereira et al. [62] | 2016 | Observational, cross-sectional study | 43 men and women, aged 18–60 y | A high GI of the diet was negatively correlated with AD concentrations (r = −0.47; p = 0.0017). |
AlEssa et al. [64] | 2016 | Cross-sectional study | 2458 women, free of diabetes, aged 43–70 y | Women from the highest quintile of diet GI had significantly lower AD concentrations compared to women from the lowest quintile (11.7 (11.2, 12.3) μg/mL vs. 12.9 (12.4, 13.4) μg/mL; p < 0.001). |
Meshkini et al. [11] | 2018 | Cross-sectional study | 89 apparently healthy women and men, aged 18–75 y | AD concentrations were negatively correlated with diet GI (r = −0.43; p < 0.001) and GL (r = −0.29; p = 0.007). A high GI diet was one of stronger negative predictors of AD concentrations (β = −0.176, p = 0.04). |
SATURATED FATTY ACIDS AND TRANS FATTY ACIDS | ||||
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of trans fatty acid consumption had significantly lower total AD concentrations (13.5 ± 1.03 μg/mL vs. 14.96 ± 1.03 μg/mL, p = 0.0002) and AD HMW concentrations (4.49 ± 1.04 μg/mL vs. 5.20 ± 1.04 μg/mL; p = 0.0008) compared to women from the lowest quartile. |
Haidari et al. [111] | 2014 | Case-control study | 94 men and women apparently healthy or with asthma | AD concentrations were negatively correlated with SFA consumption in persons with asthma (r = −0.319; p = 0.033) and in healthy individuals (r = −0.356; p = 0.016). |
Pereira et al. [62] | 2016 | Observational, cross-sectional study | 43 men and women, aged 18–60 y | AD concentrations were negatively related to the consumption of trans fatty acids (r = −0.4, p = 0.008). |
Prates et al. [27] | 2016 | Cross-sectional study | 122 men and women with T1DM, aged > 18 y | AD concentrations were negatively correlated with SFA consumption (r = −0.25, p = 0.004), total fat consumption (r = −0.20, p = 0.02), and cholesterol consumption (r = −0.20, p = 0.021). |
Lepsch et al. [110] | 2016 | Prospective cohort study | 201 pregnant women, aged 22–31 y | A negative correlation between SFA consumption and AD concentrations (β = −41.039; p = 0.008). |
MONOSACCHARIDES AND DISACCHARIDES | ||||
Pollock et al. [113] | 2012 | Cross-sectional study | 559 adolescents, aged 14–18 y | A diet with high fructose content was associated with significantly lower AD concentrations (8.4 ± 0.4 μg/mL vs. 9.1 ± 0.4 μg/mL; p = 0.033). |
Rezvani et al. [112] | 2013 | Double-blind parallel arm study | 32 overweight or obese men and women, aged 40–72 years | Participants who consumed high quantities of glucose (p = 0.028) and fructose (p = 0.0011) had significantly decreased AD concentrations after 10 weeks. |
Magalhaes et al. [114] | 2014 | Cross-sectional study | 60 obese women with nonalcoholic fatty liver disease or apparently healthy, aged >20 y | Diet rich in sucrose was significantly related to low AD concentrations (<0.35 μg/mL) in healthy women (p = 0.054) and in women with NAFLD (p = 0.045). Diet rich in sweets (p = 0.046) and sweetened beverages (p = 0.054) was significantly correlated with low AD concentrations in healthy women (<0.35 μg/mL). |
RED MEAT | ||||
Fargnoli et al. [13] | 2008 | Prospective cohort study | 1922 women free of CVD, diabetes and cancer, aged 30–55 y | Women from the highest quartile of the red meat to poultry consumption ratio had significantly lower total AD concentrations (13.24 ± 1.03 μg/mL vs. 14.52 ± 1.03 μg/mL, p = 0.02) compared to women from the lowest quartile. |
Ley et al. [116] | 2014 | Prospective cohort study | 21700 women, aged 30–55 y | Women from the highest quartile of the consumption of red meat (13.7 (13.1, 14.3) μg/mL vs. 15.0 (14.4, 15.6) μg/mL, p = 0.003), unprocessed red meat (14.0 (13.4, 14.5) μg/mL vs. 15.0 (14.4, 15.6) μg/mL; p = 0.01) and processed red meat (13.9 (13.3, 14.5) μg/mL vs. 15.0 (14.4, 15.6) μg/mL; p = 0.007) had significantly lower AD concentrations compared to women from the lowest quartile. |
Chai et al. [115] | 2017 | Case-control study | 1223 men and women free of cancer, aged 45–75 y | The consumption of red processed meat was associated with reduced AD concentrations in women (β = −0.082; p = 0.005). |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Janiszewska, J.; Ostrowska, J.; Szostak-Węgierek, D. The Influence of Nutrition on Adiponectin—A Narrative Review. Nutrients 2021, 13, 1394. https://doi.org/10.3390/nu13051394
Janiszewska J, Ostrowska J, Szostak-Węgierek D. The Influence of Nutrition on Adiponectin—A Narrative Review. Nutrients. 2021; 13(5):1394. https://doi.org/10.3390/nu13051394
Chicago/Turabian StyleJaniszewska, Justyna, Joanna Ostrowska, and Dorota Szostak-Węgierek. 2021. "The Influence of Nutrition on Adiponectin—A Narrative Review" Nutrients 13, no. 5: 1394. https://doi.org/10.3390/nu13051394
APA StyleJaniszewska, J., Ostrowska, J., & Szostak-Węgierek, D. (2021). The Influence of Nutrition on Adiponectin—A Narrative Review. Nutrients, 13(5), 1394. https://doi.org/10.3390/nu13051394